VR Adviser’s Aptose Biosciences, Inc. APTO Stock Holding History

VR Adviser’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,568	Closed	-$9.59M	–	35
2021 Q1	$9.59M	Buy	+3,568	New	+$7.07M	1.04%	20

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return

VR Adviser's APTO Position: Q2 2021 in Review

VR Adviser sold out of Aptose Biosciences, Inc. (APTO) in Q2 2021, closing a stake of 3,568 shares — an estimated $9.59M sold.

VR Adviser first reported a position in APTO in Q1 2021 and held it in 1 quarter. The position peaked at $9.59M in Q1 2021. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.

VR Adviser reported no remaining Aptose Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
VR Adviser sold 3,568 Aptose Biosciences, Inc. shares in Q2 2021, an estimated $9.59M.
VR Adviser first reported a position in Aptose Biosciences, Inc. in Q1 2021 and held it in 1 quarter.
VR Adviser's Aptose Biosciences, Inc. position peaked at $9.59M in Q1 2021.
63 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2021.

Based on VR Adviser's 13F filing for Q2 2021, filed 13 Aug 2021.